Thorac Cardiovasc Surg 2025; 73(S 02): S77-S103
DOI: 10.1055/s-0045-1804228
Monday, 17 February
NEUES AUS DER BILDGEBUNG VON ANGEBORENEN HERZFEHLERN

Prognostic Value of Cardiac Magnetic Resonance in Fontan Patients—A Multicenter Study

H. Latus
1   University Children’s Hospital Tübingen, Tübingen, Deutschland
,
L. Pesch
3   Olgahospital, Klinikum Stuttgart, Stuttgart, Deutschland
,
G. Kerst
3   Olgahospital, Klinikum Stuttgart, Stuttgart, Deutschland
,
B. Waschulzik
4   Technical University Munich, Munich, Deutschland
,
C. Meierhofer
2   German Heart Centre Munich, Munich, Deutschland
,
N. Shehu
2   German Heart Centre Munich, Munich, Deutschland
,
P. Ewert
2   German Heart Centre Munich, Munich, Deutschland
,
I. Voges
5   University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Deutschland
,
J.H. Hansen
5   University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Deutschland
,
A. Uebing
1   University Children’s Hospital Tübingen, Tübingen, Deutschland
,
A. Hanser
1   University Children’s Hospital Tübingen, Tübingen, Deutschland
,
P. Krumm
6   University Hospital Tübingen, Tübingen, Deutschland
,
J. Nordmeyer
1   University Children’s Hospital Tübingen, Tübingen, Deutschland
,
A.E. Blank
7   University Children’s Hospital Giessen, Giessen, Deutschland
,
K. Gummel
7   University Children’s Hospital Giessen, Giessen, Deutschland
,
C. Jux
7   University Children’s Hospital Giessen, Giessen, Deutschland
,
L.V. Laser
8   Philipps Universität, Marbug, Deutschland
,
S. Schubert
9   Ruhr-University of Bochum, Bad Oeynhausen, Deutschland
,
K.T. Laser
9   Ruhr-University of Bochum, Bad Oeynhausen, Deutschland
› Institutsangaben

Background: Patients with a Fontan circulation experience significant long-term morbidity and mortality. Our study aimed to determine CMR-based risk factors for adverse outcomes in a larger cohort of Fontan patients.

Methods: This retrospective multicenter study included 502 Fontan patients (mean age 15.4 ± 9.7 years) from five congenital heart disease centers in Germany, who underwent CMR as part of routine clinical care. Feature tracking analysis was performed to quantify systolic and diastolic strain values of the single ventricle. If available, flow measurements in the ascending aorta (Ao), inferior (IVC) and superior caval veins (SVC) were assessed and systemic-to-pulmonary collateral flow (SPC) was quantified (= Ao − [SVC + IVC]). The combined end-point consisted of death, heart transplantation (HT), or listing for HT.

Results: Over a median follow-up of 6.6 years (range 0.1–15.6), 39 patients reached the primary endpoint (cardiac death n = 30, HT n = 9). Univariate Cox regression analysis identified that increased single-ventricle EDVi (HR 1.01, 95% CI 1.00–1.01, p < 0.001) and ESVi (HR 1.01, 95% CI 1.01–1.02, p < 0.001) as well as reduced EF (HR 0.97, 95% CI 0.95–10.0, p = 0.02), impaired systolic longitudinal strain (HR 1.10, 95% CI 1.01–1.20, p = 0.03), and circumferential early diastolic strain rate (HR 0.16, 95% CI 0.03–0.95, p = 0.04) were significantly associated with adverse outcomes. In a subgroup of 342 subjects with complete flow measurements, higher SPC flow independently predicted death and HT (HR 1.75, 95% CI 1.05–2.93, p = 0.03) regardless of single ventricle size and function.

Conclusion: Fontan patients with dilated single ventricles and impaired systolic function are at an increased risk for adverse events. Elevated SPC flow emerged as an independent risk factor, suggesting the need to explore underlying mechanisms and effective occlusion strategies for these collaterals.



Publikationsverlauf

Artikel online veröffentlicht:
11. Februar 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany